Abrysvo vial with diluent syrgs
Ended Awarded
- Contract number
- SPE2DB25FQDR4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $0
Award facts
- Contract value 0% obligated
-
- $0.00 Current, with exercised options
- $4,002.40 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,002.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Abrysvo vial with diluent syringes, with an ultimate completion date of April 9, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million and extends through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio of federal contract awards encompasses a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical commodities. As a competitively awarded contractor with demonstrated capability to meet federal procurement requirements, AmerisourceBergen continues to fulfill diverse medical supply needs across multiple therapeutic domains for defense and civilian government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQDR4?
SPE2DB25FQDR4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 8, 2025.
How much is contract SPE2DB25FQDR4 worth?
The government has obligated $0 on SPE2DB25FQDR4. Its potential value, with all options, is $4,002.
Is contract SPE2DB25FQDR4 an order under another contract?
Yes. SPE2DB25FQDR4 is a delivery order under SPE2DB20D7059, an indefinite delivery contract.
Was contract SPE2DB25FQDR4 competed?
The extent of competition for SPE2DB25FQDR4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award